News · 26 weeks37-100%
2026-04-192026-10-11
Mix2290d
- Insider12(55%)
- SEC Filings6(27%)
- Other2(9%)
- Earnings1(5%)
- Analyst1(5%)
Latest news
25 items- INSIDERDirector Mecca Robert converted options into 1,587 shares, increasing direct ownership by 225% to 2,291 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Langston Cynthia converted options into 1,587 shares, increasing direct ownership by 86% to 3,424 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Kaniki Mbago M. converted options into 1,587 shares, increasing direct ownership by 61% to 4,180 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Haseley Gary J. converted options into 1,587 shares, increasing direct ownership by 4% to 40,689 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Gillette Christopher P. converted options into 1,587 shares, increasing direct ownership by 794% to 1,787 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Deperrior Dawn converted options into 1,587 shares, increasing direct ownership by 225% to 2,291 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Dominach Oksana S. converted options into 1,587 shares, increasing direct ownership by 37% to 5,933 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Cairns Craig D. converted options into 1,587 shares, increasing direct ownership by 32% to 6,590 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- SECTranscat Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - TRANSCAT INC (0000099302) (Filer)
- SECSEC Form S-3ASR filed by Transcat Inc.S-3ASR - TRANSCAT INC (0000099302) (Filer)
- INSIDERDirector Dominach Oksana S. sold $625,876 worth of shares (7,312 units at $85.60), decreasing direct ownership by 63% to 4,346 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- PRTranscat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern BiomedicalAcquisition Expands Accredited Biomedical Calibration Capabilities, Equipment Repair, and Preventative Maintenance Services and Strengthens Transcat's Presence with Hospital Networks and Healthcare Facilities Throughout the Southeastern United StatesSoutheastern Biomedical Owners will Remain with Transcat to Drive Growth of the Combined Biomedical BusinessTranscat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leading provider of accredited calibration services and test and measurement equipment, announced that it has acquired privately-held Southeastern Biomedical Associates Incorporated ("Southeastern") effective August 31, 2026.The $12.8 million purchase price was paid in cash and i
- PRTranscat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in SeptemberTranscat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leading provider of test measurement, control and calibration, today announced that management will attend the 2026 Jefferies Global Industrials Conference, Lake Street Capital Markets 10th Annual Best Ideas Growth ("BIG10") Conference, and D.A. Davidson 25th Annual Diversified Industrials & Services Conference in September 2026. Transcat President and Chief Executive Officer Jaime Irick and Chief Financial Officer Thomas Barbato will attend the 2026 Jefferies Global Industrials Conference and the Lake Street Capital Markets 10th Annual Best Ideas Growth ("BIG10") Conference, where they are scheduled to host one-on-one meetings
- INSIDERDirector Dominach Oksana S. exercised 10,000 shares at a strike of $26.27 and covered exercise/tax liability with 2,688 shares, increasing direct ownership by 168% to 11,658 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Gillette Christopher P. sold $47,494 worth of shares (504 units at $94.23), decreasing direct ownership by 72% to 200 units (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERDirector Cairns Craig D. bought $98,663 worth of shares (1,050 units at $93.97) (SEC Form 4)4 - TRANSCAT INC (0000099302) (Issuer)
- ANALYSTTranscat downgraded by Northland Capital with a new price targetNorthland Capital downgraded Transcat from Outperform to Market Perform and set a new price target of $95.00
- SECSEC Form 10-Q filed by Transcat Inc.10-Q - TRANSCAT INC (0000099302) (Filer)
- SECTranscat Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - TRANSCAT INC (0000099302) (Filer)
- PRTranscat Reports Strong Fiscal First Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Service Gross Margin ExpansionQ1’27 Revenue Increased 22% to $92.9 Million Q1’27 Service Revenue Increased 27% to $62.6 Million Q1’27 Service Gross Margin Expanded 90 Basis Points to 33.9% Q1’27 Distribution Revenue Grew 11% to $30.4 Million on Strong Demand for Rentals Management to Host Conference Call Today at 4:30 p.m. Eastern Time Transcat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leader in test measurement, control and calibration, has reported its financial and operational results for its fiscal first quarter ended June 27, 2026 (the "first quarter") of fiscal year 2027. Management Commentary First 100 Days "Prior to discussing our strong financial performance, I want to share my
- SECSEC Form DEFA14A filed by Transcat Inc.DEFA14A - TRANSCAT INC (0000099302) (Filer)
- SECSEC Form DEF 14A filed by Transcat Inc.DEF 14A - TRANSCAT INC (0000099302) (Filer)
- PRTranscat to Host First Quarter Fiscal Year 2027 Conference Call and Webcast on Tuesday, August 4, 2026 at 4:30 p.m. Eastern TimeTranscat, Inc. (NASDAQ:TRNS) ("Transcat" or the "Company"), a leading provider of test measurement, control and calibration, announced that it will release its results for the first quarter fiscal year 2027 ended June 27, 2026 after the close of financial markets on Tuesday, August 4, 2026. Transcat President and Chief Executive Officer Jaime Irick and Chief Financial Officer Thomas Barbato will host a conference call and webcast on Tuesday, August 4, 2026 at 4:30 p.m. ET to review the financial and operating results for the period and discuss its corporate strategy and outlook. A question-and-answer session will follow. First Quarter Fiscal Year 2027 Conference Call Tuesday, August 4,
- INSIDERSEC Form 4 filed by Chief Strat. & CorpDev Officer Simmons Royal Thomas Jr.4 - TRANSCAT INC (0000099302) (Issuer)
- INSIDERSEC Form 3 filed by new insider Simmons Royal Thomas Jr.3 - TRANSCAT INC (0000099302) (Issuer)
TRNS FAQ
6 questionsWhat does Transcat Inc. do?
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management software that is used to integrate and manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides...Where does TRNS stock trade?
Transcat Inc. (TRNS) is listed on NASDAQ.What sector and industry is TRNS in?
Transcat Inc. operates in the Industrials sector, Electrical Products industry.What are analysts saying about TRNS?
Transcat Inc. has had 8 recent analyst actions on file. The most recent action was from Northland Capital: Market Perform on 2026-08-05.What companies are similar to TRNS?
Notable peers in the same industry include APH (Amphenol Corporation), ABB (ABB Ltd), TER (Teradyne Inc.), FLEX (Flex Ltd.), CLS (Celestica Inc.). Compare TRNS side-by-side with any of them on Quantisnow.How can I track TRNS on Quantisnow?
Quantisnow aggregates Transcat Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TRNS to receive live email and push alerts on every new disclosure.